Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-020616
Filing Date
2026-04-30
Accepted
2026-04-30 16:40:17
Documents
20
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 682827
2 GRAPHIC formdef14a_001.jpg GRAPHIC 2319
3 GRAPHIC formdef14a_002.jpg GRAPHIC 2298
4 GRAPHIC formdef14a_003.jpg GRAPHIC 3280
5 GRAPHIC proxy_001.jpg GRAPHIC 274974
6 GRAPHIC proxy_002.jpg GRAPHIC 295184
7 GRAPHIC proxy_003.jpg GRAPHIC 428509
8 GRAPHIC proxy_004.jpg GRAPHIC 389364
  Complete submission text file 0001493152-26-020616.txt   4362423

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE bfri-20251231.xsd EX-101.SCH 3434
10 XBRL DEFINITION FILE bfri-20251231_def.xml EX-101.DEF 3377
11 XBRL LABEL FILE bfri-20251231_lab.xml EX-101.LAB 53652
12 XBRL PRESENTATION FILE bfri-20251231_pre.xml EX-101.PRE 44059
23 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 1263
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40943 | Film No.: 26926412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)